Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer
JAMA
.
2024 Jul 23;332(4):337.
doi: 10.1001/jama.2024.10480.
Authors
Hengjia Tu
1
,
Yuzhuo Zhang
1
,
Zhixuan You
1
Affiliation
1
National Cancer Center, Chinese Academy of Medical Sciences, Beijing, China.
PMID:
38958961
PMCID:
PMC12341650
DOI:
10.1001/jama.2024.10480
No abstract available
Publication types
Letter
Comment
MeSH terms
Female
Humans
Lymphocytes, Tumor-Infiltrating* / immunology
Middle Aged
Prognosis
Triple Negative Breast Neoplasms* / immunology
Grants and funding
P50 CA116201/CA/NCI NIH HHS/United States